Clinical Trials Browser

Advanced Malignancies × Midazolam × 30 days × Clear all

NCT07426757 2026-06-01

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Phase 1 Recruiting

Advanced Malignancies